Glaucoma is a group of eye diseases that can cause vision loss and blindness by damaging a nerve in the back of your eye called the optic nerve. The symptoms can start so slowly that a patient may not notice them. The only way to find out if a person has glaucoma is to get a comprehensive dilated eye exam. Glaucoma may occur among people with or without diabetes. Moreover, people with diabetic retinopathy have an increased risk of glaucoma. The condition is associated with abnormal blood vessel growth, which can result in retinopathy and leads to blockage of natural drainage of the eye. Rapidly increasing geriatric population is one of the important factors for the increasing prevalence of glaucoma, which in turn is projected to drive the growth of the glaucoma therapeutics market in the near future.
Market Dynamics
The global glaucoma eye drops market is expected to witness significant growth during the forecast period owing to the increasing prevalence of glaucoma. For instance, according to the Centre for Disease Control and Prevention, in November 2020, an estimated 3 Mn people suffered from blindness due to glaucoma in the U.S. 2020.
Key features of the study:
- This report provides in-depth analysis of the global glaucoma eye drops market, market size (US$ Mn), and compound annual growth rate (CAGR (%) for the forecast period: 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global glaucoma eye drops market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include Merck KGaA, Allergan plc ( A subsidiary of AbbVie Inc.), Novartis AG, Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Bausch & Lomb, Inotek, Jadran-galenski laboratorij d.d. JGL d.d, Aerie Pharmaceutical (A subsidiary of Alcon Management S. A) and Mylan N.V (A subsidiary of Viatris Inc.)
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics.
- The global glaucoma eye drops market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for glaucoma eye drops, research and consulting firms, new entrants, and financial analysts.
- Global Glaucoma Eye Drops Market, By Drug Type:
- Prostaglandin analogs
- Beta blockers
- Alpha agonists
- Carbonic Anhydrase Inhibitors (CAIs)
- Combined Medications
- Others (rho-kinase inhibitor, Cholinergic agonist)
- Global Glaucoma Eye Drops Market, By Disease Indication:
- Angle-closure Glaucoma
- Open-angle Glaucoma
- Global Glaucoma Eye Drops Market, By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Global Glaucoma Eye Drops Market, By Composition:
- Preservative Free
- BAK-Based
- Non BAK-Based Preservatives
- Global Glaucoma Eye Drops Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Merck KGaA
- Allergan plc ( A subsidiary of AbbVie Inc)
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Pfizer, Inc.
- Bausch & Lomb
- Inotek
- Jadran-galenski laboratorij d.d. JGL d.d
- Aerie Pharmaceutical (A subsidiary of Alcon Management S. A)
- Mylan N.V. (A subsidiary of Viatris Inc.)
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Disease Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Composition
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaboration
- Regulatory Scenario
- Key Developments
- PEST Analysis
- 4. Global Glaucoma Eye Drops Market– COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
- 5. Global Glaucoma Eye Drops Market, By Drug Type, 2020–2032, (US$ Million)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Prostaglandin analogs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Beta blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Alpha agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Carbonic Anhydrase Inhibitors (CAIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Combined Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- 6. Global Glaucoma Eye Drops Market, By Disease Indication, 2020–2032, (US$ Million)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Angle-closure Glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Open-angle Glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- 7. Global Glaucoma Eye Drops Market, By Distribution Channel, 2020–2032, (US$ Million)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- 8. Global Glaucoma Eye Drops Market, By Composition, 2020–2032, (US$ Million)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Preservative Free
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- BAK-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Non BAK-Based Preservatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- 9. Global Glaucoma Eye Drops Market, By Region, 2020–2032, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021–2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Million)
- North Africa
- Central Africa
- South Africa
- 10. Competitive Landscape
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Allergan plc ( A subsidiary of AbbVie Inc)
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Pfizer, Inc.
- Bausch & Lomb
- Inotek
- Jadran-galenski laboratorij d.d. JGL d.d
- Aerie Pharmaceutical (A subsidiary of Alcon Management S. A)
- Mylan N.V. (A subsidiary of Viatris Inc.)
- 11. Section
- Research Methodology
- About Us
- *Browse 43 market data tables and 37 figures on “Glaucoma Eye Drops Market” - forecast to 2032
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook